• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 709

Pyrroloquinoline quinone disodium salt

Intended Use: For use as an ingredient in energy, sport, and electrolyte drinks; bottled, enhanced, and fortified water; and non-milk based meal replacement beverages at a maximum use level of up to 8 to 20 mg/serving.
Basis: Scientific procedures
Notifier: Shandong Jincheng Bio-Pharmaceutical Co., Ltd.
Notifier Address: Zichuan Economic Development Zone
Zibo City, Shandong Province
GRAS Notice (releasable information): GRN 709 (in PDF) (1.55 MB)
Date of closure: Mar 6, 2018
FDA's Letter: FDA has no questions (in PDF) (79 kB)